acc43551 |
Tumor protein D53 |
oxidation |
Met90 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43552 |
Heterochromatin protein 1-binding protein 3 |
oxidation |
Met353 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43553 |
Histone H3.2 |
oxidation |
Met91 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43554 |
Large ribosomal subunit protein mL55 |
oxidation |
Met74 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43555 |
THO complex subunit 4 |
oxidation |
Met5 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43556 |
Cullin-associated NEDD8-dissociated protein 1 |
oxidation |
Met367 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43557 |
Myosin-IIIa |
oxidation |
Met778 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43558 |
Nuclear pore membrane glycoprotein 210 |
oxidation |
Met1241 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43559 |
Peptidyl-prolyl cis-trans isomerase FKBP10 |
oxidation |
Met446 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43560 |
Parkinson disease protein 7 |
oxidation |
Met26 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43561 |
T-complex protein 1 subunit eta |
oxidation |
Met382 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43562 |
T-complex protein 1 subunit eta |
oxidation |
Met1 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43563 |
Tubulin alpha-1C chain |
oxidation |
Met377 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43564 |
Peroxiredoxin-like 2A |
oxidation |
Met101 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43565 |
"Acetyl-CoA acetyltransferase, cytosolic" |
oxidation |
Met264 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43566 |
Protein MAK16 homolog |
oxidation |
Met1 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43567 |
SH3 domain-binding glutamic acid-rich-like protein 3 |
oxidation |
Met50 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43568 |
Centromere protein H |
oxidation |
Met60 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43569 |
Centromere protein H |
oxidation |
Met73 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43570 |
Charged multivesicular body protein 1a |
oxidation |
Met1 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43571 |
Adipocyte plasma membrane-associated protein |
oxidation |
Met112 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43572 |
H/ACA ribonucleoprotein complex subunit 3 |
oxidation |
Met1 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43573 |
Putative RNA-binding protein Luc7-like 1 |
oxidation |
Met177 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43574 |
Putative RNA-binding protein Luc7-like 2 |
oxidation |
Met177 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43575 |
SUMO-activating enzyme subunit 1 |
oxidation |
Met65 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43576 |
Jupiter microtubule associated homolog 1 |
oxidation |
Met47 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43577 |
RNA-binding protein Raly |
oxidation |
Met89 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43578 |
Protein CDV3 homolog |
oxidation |
Met103 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43579 |
Pre-mRNA-processing factor 19 |
oxidation |
Met370 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43580 |
Nucleolar protein 58 |
oxidation |
Met64 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43581 |
Chromatin target of PRMT1 protein |
oxidation |
Met41 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43582 |
Small nuclear ribonucleoprotein G |
oxidation |
Met69 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43583 |
Putative small nuclear ribonucleoprotein G-like protein 15 |
oxidation |
Met69 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43584 |
"Nascent polypeptide-associated complex subunit alpha, muscle-specific form" |
oxidation |
Met2048 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43585 |
Eukaryotic translation initiation factor 3 subunit F |
oxidation |
Met253 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43586 |
ATP-dependent RNA helicase DDX3X |
oxidation |
Met352 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43587 |
ATP-dependent RNA helicase DDX3Y |
oxidation |
Met350 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43588 |
Probable ATP-dependent RNA helicase DDX5 |
oxidation |
Met253 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43589 |
Probable ATP-dependent RNA helicase DDX17 |
oxidation |
Met330 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43590 |
ATP-dependent RNA helicase DDX3X |
oxidation |
Met355 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43591 |
ATP-dependent RNA helicase DDX3Y |
oxidation |
Met353 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43592 |
Probable ATP-dependent RNA helicase DDX5 |
oxidation |
Met256 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43593 |
Probable ATP-dependent RNA helicase DDX17 |
oxidation |
Met333 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43594 |
AP-3 complex subunit delta-1 |
oxidation |
Met964 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43595 |
Myosin regulatory light chain 12A |
oxidation |
Met56 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43596 |
Myosin regulatory light chain 12B |
oxidation |
Met57 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43597 |
Myosin regulatory light polypeptide 9 |
oxidation |
Met57 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43598 |
Actin-related protein 2/3 complex subunit 3 |
oxidation |
Met19 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|
acc43599 |
D-3-phosphoglycerate dehydrogenase |
oxidation |
Met306 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Positive |
3.0 |
PXD052364
|
acc43600 |
D-3-phosphoglycerate dehydrogenase |
oxidation |
Met477 |
human |
Endometrial Cancer |
ECC-1 |
DEAB |
Negative |
3.0 |
PXD052364
|